Date published: 2025-9-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

25-Desacetyl Rifampicin (CAS 16783-99-6)

0.0(0)
Write a reviewAsk a question

Alternate Names:
25-O-Deacetyl-3-[(E)-[(4-methyl-1-piperazinyl)imino]methyl]rifamycin; 25-Deacetylrifampicin
Application:
25-Desacetyl Rifampicin is a metabolite of Rifampicin
CAS Number:
16783-99-6
Purity:
≥95%
Molecular Weight:
780.90
Molecular Formula:
C41H56N4O11
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

25-Desacetyl Rifampicin is a metabolite of Rifampicin. Utilizing 25-Desacetyl Rifampicin, researchers have conducted laboratory studies aiming to unravel the impacts of rifampicin on diverse biological processes. Its application spans the investigation of rifampicin′s mechanisms of action, elucidating its effects on both bacterial and mammalian cell cultures. Moreover, 25-Desacetyl Rifampicin has played a role in studying the influence of rifampicin on gene expression and protein synthesis.


25-Desacetyl Rifampicin (CAS 16783-99-6) References

  1. Rifampicin bioavailability: a review of its pharmacology and the chemotherapeutic necessity for ensuring optimal absorption.  |  Ellard, GA. and Fourie, PB. 1999. Int J Tuberc Lung Dis. 3: S301-8; discussion S317-21. PMID: 10593709
  2. The WHO simplified study protocol in practice: investigation of combined formulations supplied by the WHO.  |  Panchagnula, R., et al. 1999. Int J Tuberc Lung Dis. 3: S336-42; discussion S351-2. PMID: 10593714
  3. Evaluation of the recently reported USP gradient HPLC method for analysis of anti-tuberculosis drugs for its ability to resolve degradation products of rifampicin.  |  Mohan, B., et al. 2003. J Pharm Biomed Anal. 31: 607-12. PMID: 12615251
  4. Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs.  |  Bhutani, H., et al. 2005. J Pharm Biomed Anal. 39: 892-9. PMID: 15978767
  5. Control and analysis of hydrazine, hydrazides and hydrazones--genotoxic impurities in active pharmaceutical ingredients (APIs) and drug products.  |  Elder, DP., et al. 2011. J Pharm Biomed Anal. 54: 900-10. PMID: 21145684
  6. A bioequivalence comparison of two formulations of rifampicin (300- vs 150-mg capsules): An open-label, randomized, two-treatment, two-way crossover study in healthy volunteers.  |  Chik, Z., et al. 2010. Clin Ther. 32: 1822-31. PMID: 21194606
  7. Fatal poisoning by isoniazid and rifampicin.  |  Sridhar, A., et al. 2012. Indian J Nephrol. 22: 385-7. PMID: 23326053
  8. Troubleshooting carry-over of LC-MS/MS method for rifampicin, clarithromycin and metabolites in human plasma.  |  Vu, DH., et al. 2013. J Chromatogr B Analyt Technol Biomed Life Sci. 917-918: 1-4. PMID: 23353809
  9. Relationship between CES2 genetic variations and rifampicin metabolism.  |  Song, SH., et al. 2013. J Antimicrob Chemother. 68: 1281-4. PMID: 23471941
  10. Aggregate culture of human embryonic stem cell-derived hepatocytes in suspension are an improved in vitro model for drug metabolism and toxicity testing.  |  Sengupta, S., et al. 2014. Toxicol Sci. 140: 236-45. PMID: 24752503
  11. Population Pharmacokinetic Analysis of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children with Tuberculous Meningitis.  |  Abdelgawad, N., et al. 2023. Antimicrob Agents Chemother. 67: e0147422. PMID: 36815838
  12. In vitro effect of rifampicin and its derivatives on energy transfer reactions in mitochondria.  |  Inouye, B., et al. 1974. J Antibiot (Tokyo). 27: 192-8. PMID: 4275810
  13. Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method.  |  Panchagnula, R., et al. 1999. J Pharm Biomed Anal. 18: 1013-20. PMID: 9925337

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

25-Desacetyl Rifampicin, 1 mg

sc-206558
1 mg
$265.00